サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455673

リフトバレー熱ワクチン市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Rift Valley Fever Vaccines Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
リフトバレー熱ワクチン市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

リフトバレー熱ワクチンの市場規模は2023年に2億1,045万米ドルとなり、2024年から2032年にかけてCAGR 6.2%で拡大すると予測されています。

リフトバレー熱ワクチン市場 - 市場力学

公衆衛生教育と社会・医療環境の進歩による認知度の向上が市場需要を促進

リフトバレー熱ワクチン市場は、公衆衛生教育による意識の高まりと社会・医療環境の進歩により、大きな成長を遂げています。技術の進歩により、医療や動物の専門家がヒトと動物の両方に効率的にワクチンを接種できるようになり、市場の拡大をさらに促進しています。リフトバレー熱ワクチンの促進要因としては、特に流行地域でリフトバレー熱の流行が増加しており、効果的な予防対策の緊急性が高まっていることが挙げられます。さらに、リフトバレー熱の経済的・公衆衛生的影響に対する政府、ヘルスケア機関、農業セクターの意識の高まりは、疾病管理への積極的アプローチとしてのワクチン接種の重要性を強調しています。さらに、ワクチン技術と研究の進歩は、業界の利害関係者と規制機関の協力的な取り組みと相まって、リフトバレー熱ワクチンの開発と入手のしやすさに貢献しています。これらの要因から、リフトバレー熱の蔓延を緩和し、関連する罹患率や死亡率を減少させる上で、ワクチン接種が極めて重要な役割を果たすことが強調されています。しかし、潜在的な副反応に関する懸念は、これらのポジティブな要因にもかかわらず、市場の成長を阻害する可能性があります。

リフトバレー熱ワクチン市場 - 主要洞察

世界市場は予測期間（2024年～2032年）に約6.2%のCAGRで毎年成長すると予測されています。

製品タイプ別では、生ワクチンが2023年に最大の市場シェアを示すと予測されています。

用途別では、2023年には牛が主要タイプとなっています。

地域別では、北米が2023年に主要な収益源となりました。

リフトバレー熱ワクチン市場 - セグメンテーション分析：

リフトバレー熱ワクチンの世界市場は、製品タイプ、用途、地域に基づいてセグメント化されます。

市場は製品タイプによって、不活化ワクチンと生ワクチンの2つのカテゴリーに分けられます。リフトバレー熱ワクチン市場において、生ワクチンは強固で持続的な免疫反応を引き起こすことができるため、製品タイプ別では生ワクチンが優位を占めています。これらのワクチンには、リフトバレー熱ウイルスの弱毒化または弱毒化バージョンが含まれており、病気を誘発することなく自然感染を反映しています。このため、旺盛な免疫反応が起こり、抗体や記憶細胞が生成され、将来の感染に対する防御が可能になります。生ワクチンは、その有効性と、様々な動物種や個体群に幅広い免疫を与える可能性が評価され、リフトバレー熱のワクチン接種に好ましい選択肢となっています。

市場は用途別に、牛、ヤギ、人、羊、その他の5つのカテゴリーに分けらます。用途別では、2023年には牛の分野が市場の支配的なセクターとして浮上しました。牛はリフトバレー熱ウイルス感染に非常に脆弱であり、家畜の間で発生すると農家や農業部門に大きな経済的影響を及ぼす可能性があります。リフトバレー熱に対する牛のワクチン接種は、病気の蔓延を防ぎ、罹患率と死亡率を低下させ、農家の生活を守るのに役立ちます。さらに、牛をリフトバレー熱から守ることは、食糧安全保障を維持し、人獣共通感染症のヒトへの感染を回避するために極めて重要であり、この極めて重要な動物集団を対象としたワクチン接種の取り組みの重要性を強調しています。

リフトバレー熱ワクチン市場 - 地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

リフトバレー熱ワクチン市場 - 競合情勢：

リフトバレー熱ワクチン市場では、企業は効果的で利用しやすいワクチンの開発を進めるため、多様な戦略を実施しています。これらの戦略には、ワクチン製剤の改良、投与レジメンの改良、ワクチンの安定性向上など、特に資源に乏しい環境での保管や輸送を容易にするための継続的な研究が含まれます。さらに企業は、ワクチン開発、規制当局による承認、流通のプロセスを合理化するために、政府、国際機関、研究機関との協力に取り組んでいます。さらに、リフトバレー熱の発生を抑制し、動物と人間の健康を守るためのワクチン接種の重要性について、農家、獣医師、ヘルスケア従事者の意識を高めるための教育キャンペーンも実施されています。

目次

第1章 リフトバレー熱ワクチン市場の概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 リフトバレー熱ワクチンの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 リフトバレー熱ワクチンの産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 リフトバレー熱ワクチン市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 リフトバレー熱ワクチン市場情勢

  • リフトバレー熱ワクチン市場シェア分析（2023年）
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 リフトバレー熱ワクチン市場：製品タイプ別

  • 概要
    • セグメントシェア分析：製品タイプ別
    • 不活化ワクチン
    • 生ワクチン

第8章 リフトバレー熱ワクチン市場：用途別

  • 概要
    • セグメントシェア分析：用途別
    • 牛
    • ヤギ
    • ヒト
    • 羊
    • その他

第9章 リフトバレー熱ワクチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：リフトバレー熱ワクチン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Veterinary Serum and Vaccine Research Institute
    • Medgene Labs
    • VSVRI
    • Onderstepoort Biological Products
    • OBP
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rift Valley Fever Vaccines Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rift Valley Fever Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rift Valley Fever Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rift Valley Fever Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rift Valley Fever Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Europe Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Latin America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Germany Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE India Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2336

REPORT HIGHLIGHT

Rift Valley Fever Vaccines Market size was valued at USD 210.45 Million in 2023, expanding at a CAGR of 6.2% from 2024 to 2032.

Rift Valley Fever is a viral illness transmitted through mosquito bites, affecting both humans and animals. The virus spreads through direct contact with infected animal blood and tissues, as well as mosquito bites. While the virus often presents without symptoms, it can lead to serious complications such as encephalitis, blindness, and hemorrhagic fever. Rift Valley Fever vaccines come in two forms: live attenuated RVF vaccine (Smithburn strain) and killed vaccine. Vaccination protects both humans and animals, crucial for food security and economic stability. These vaccines are essential in preventing the spread of this zoonotic disease, playing a significant role in livestock management and public health initiatives, particularly in endemic areas where RVF outbreaks pose substantial risks.

Rift Valley Fever Vaccines Market- Market Dynamics

Increasing awareness through public health education and advancements in social and medical landscapes to propel market demand

The Rift Valley Fever Vaccines Market is experiencing significant growth due to heightened awareness through public health education and advancements in social and medical landscapes. Technological progress enables health and animal professionals to efficiently vaccinate both humans and animals, further driving market expansion. The drivers of Rift Valley Fever vaccines include the increasing prevalence of Rift Valley Fever outbreaks, particularly in endemic regions, which heightens the urgency for effective preventive measures. Additionally, the rising awareness among governments, healthcare organizations, and agricultural sectors about the economic and public health impacts of Rift Valley Fever underscores the importance of vaccination as a proactive approach to disease control. Furthermore, advancements in vaccine technology and research, coupled with collaborative efforts between industry stakeholders and regulatory bodies, contribute to the development and accessibility of Rift Valley Fever vaccines. These drivers collectively emphasize the critical role of vaccination in mitigating the spread of Rift Valley Fever and reducing its associated morbidity and mortality rates. However, concerns regarding potential adverse reactions may impede market growth despite these positive factors.

Rift Valley Fever Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2024-2032)

Based on product type segmentation, Live vaccines was predicted to show maximum market share in the year 2023

Based on Application segmentation, Cattle was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Rift Valley Fever Vaccines Market- Segmentation Analysis:

The Global Rift Valley Fever Vaccines Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on product type: Inactivated and Live. Within the Rift Valley Fever vaccine market, live vaccines take precedence in the type segment due to their capacity to elicit robust and enduring immune responses. These vaccines contain weakened or attenuated versions of the Rift Valley Fever virus, mirroring natural infection without inducing illness. This prompts a vigorous immune reaction, generating antibodies and memory cells that confer protection against future infections. Live vaccines are valued for their efficacy and potential to confer broad immunity across various animal species and populations, making them the preferred option for Rift Valley Fever vaccination initiatives.

The market is divided into five categories based on Application: Cattle, Goats, People, Sheep and Other. Regarding application, in 2023, the cattle segment emerges as the dominant sector in the Rift Valley Fever vaccine market. Cattle are highly vulnerable to Rift Valley Fever virus infection, and outbreaks among livestock can carry significant economic repercussions for farmers and the agricultural sector. Vaccinating cattle against Rift Valley Fever helps prevent disease spread, diminish morbidity and mortality rates, and safeguard farmers' livelihoods. Additionally, shielding cattle from Rift Valley Fever is crucial for upholding food security and averting zoonotic transmission to humans, highlighting the significance of vaccination endeavors targeting this pivotal animal demographic.

Rift Valley Fever Vaccines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rift Valley Fever Vaccines Market- Competitive Landscape:

In the Rift Valley Fever vaccine market, companies are implementing diverse strategies to advance the development of effective and accessible vaccines. These strategies encompass continuous research aimed at enhancing vaccine formulations, refining dosing regimens, and improving vaccine stability to facilitate easier storage and transportation, particularly in resource-constrained environments. Moreover, companies are engaging in collaborations with governments, international organizations, and research institutions to streamline vaccine development, regulatory approval, and distribution processes. Additionally, educational campaigns are being conducted to raise awareness among farmers, veterinarians, and healthcare workers regarding the importance of vaccination in controlling Rift Valley Fever outbreaks and protecting both animal and human health.

Recent Developments:

In April 2023, a significant development was reported: the initiation of a phase 1 clinical trial assessing the safety of a ChAdOx1 vaccine regarding Rift Valley Fever in UK adults. This non-randomized open-label, trial represents a critical milestone in the journey toward combating Rift Valley Fever and underscores the ongoing efforts to develop effective vaccines against this viral illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIFT VALLEY FEVER VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Veterinary Serum and Vaccine Research Institute

Medgene Labs

VSVRI

Onderstepoort Biological Products

OBP

Others

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated
  • Live

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cattle
  • Goats
  • People
  • Sheep
  • Other

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Rift Valley Fever Vaccines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Rift Valley Fever Vaccines Market Snippet by Product Type
    • 2.1.2.Rift Valley Fever Vaccines Market Snippet by Application
    • 2.1.3.Rift Valley Fever Vaccines Market Snippet by Country
    • 2.1.4.Rift Valley Fever Vaccines Market Snippet by Region
  • 2.2.Competitive Insights

3.Rift Valley Fever Vaccines Key Market Trends

  • 3.1.Rift Valley Fever Vaccines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Rift Valley Fever Vaccines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Rift Valley Fever Vaccines Market Opportunities
  • 3.4.Rift Valley Fever Vaccines Market Future Trends

4.Rift Valley Fever Vaccines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Rift Valley Fever Vaccines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Rift Valley Fever Vaccines Market Landscape

  • 6.1.Rift Valley Fever Vaccines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Rift Valley Fever Vaccines Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Inactivated
    • 7.1.3.Live

8.Rift Valley Fever Vaccines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cattle
    • 8.1.3.Goats
    • 8.1.4.People
    • 8.1.5.Sheep
    • 8.1.6.Other

9.Rift Valley Fever Vaccines Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Rift Valley Fever Vaccines Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Rift Valley Fever Vaccines Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Rift Valley Fever Vaccines Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Rift Valley Fever Vaccines Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Rift Valley Fever Vaccines Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Rift Valley Fever Vaccines Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Veterinary Serum and Vaccine Research Institute
    • 10.2.2.Medgene Labs
    • 10.2.3.VSVRI
    • 10.2.4.Onderstepoort Biological Products
    • 10.2.5.OBP
    • 10.2.6.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us